I too think FDA approval of BetOnMace would be a positive....but I've seen plenty of other instances where a much anticipated piece of news finally came out, and the stock didn't react as expected...

Short interest up to Nov 30th dropped a whopping 100 shares, and was at 10,100 on that date.

As for a Zenith IPO.....Why do some seem to think that existing shares complicate things? The key letter in IPO isn't the I but the P. There are always existing shareholders when an intial offering is made to the public. Obviously there would be an underwriter involved, probably an investment banker....then its a quesiton of determining a market valuation, then just do the math.

If they say Zenith should have a market cap of 100 million, just do the arithmetic. How many new shares are going to be offered, add those to those already owned by RVX holders and BOD members...and any fees paid in shares, then divide.